A novel protein "7B2", initially isolated from human and porcine pituitary glands (Hsi et al., 1982; Seidah et al., 1983) , is distributed widely in the rat, with high concentrations in the neuroendocrine tissues (Iguchi et al., 1984) . Immunocytochemical studies revealed the presence of 7B2 in the gonadotrophs and thyrotrophs of the rat pituitary gland (Marcinkiewicz et al., 1987) . Release of 7B2 induced by high K+ and/or LHRH was also demonstrated using cultured cells of the rat pituitary gland (Iguchi et al., 1984 ; Deng et al., 1986) . These observations indicate that 7B2 is a secretory protein in the rat pituitary gland. The presence of 7B2 was also noted in the human GH-producing pituitary adenoma and an increase in plasma 7B2 after an administration of GRF was found in some patients with acromegaly but not in normal subjects (Natori et al., 1988). These findings suggest that 7B2 could be secreted by human GH-producing pituitary adenoma and its secretion is regulated by GRF.
manner.
In contrast, a somatostatin analog, SMS 201-995, revealed the inhibitory effects on the basal-and GRF-induced secretion of 7B2 at the concentration of 10-7M. These findings suggest that 7B2 is a secretory protein of rat GH1 cells under certain conditions.
A novel protein "7B2", initially isolated from human and porcine pituitary glands (Hsi et al., 1982; Seidah et al., 1983) , is distributed widely in the rat, with high concentrations in the neuroendocrine tissues (Iguchi et al., 1984) . Immunocytochemical studies revealed the presence of 7B2 in the gonadotrophs and thyrotrophs of the rat pituitary gland (Marcinkiewicz et al., 1987) . Release of 7B2 induced by high K+ and/or LHRH was also demonstrated using cultured cells of the rat pituitary gland (Iguchi et al., 1984 ; Deng et al., 1986) . These observations indicate that 7B2 is a secretory protein in the rat pituitary gland. The presence of 7B2 was also noted in the human GH-producing pituitary adenoma and an increase in plasma 7B2 after an administration of GRF was found in some patients with acromegaly but not in normal subjects (Natori et al., 1988) . These findings suggest that 7B2 could be secreted by human GH-producing pituitary adenoma and its secretion is regulated by GRF.
This work was undertaken in order to investigate 7B2 secretion under certain conditions by the rat adenomatous GH secreting cells (GH1 cells). 
Statistics
Student's t-test was performed to assess the significant difference between medium concentrations of IR-7B2 or GH in each group .
Results

Contents of IR-7B2 and GH in GHl cells
Cell contents of IR-7B2 and GH (mean fmol/mg protein, respectively.
Effects of high K+ and hGRF on the secretion of IR-7B2 and GH by GH1 cells IR-7B2 was secreted by GH1 cells and the secretion of IR-7B2 was increased about 3-fold by high K+-induced depolarization (data not shown).GH was also secreted by high K+ but the magnitude of the increase was less than that of IR-7B2 (data not shown). The medium concentration of IR-7B2 was significantly increased in the presence of 10-6M (P <0.01) and 10-5M hGRF (P< 0.01), but secretion of IR-7B2 remained unchanged in the presence of 10-7M hGRF (Fig. 1) . The medium concentration of GH was also increased in the presence of 10-5M hGRF (p<0.05) (Fig. 1) .
In the presence of 10-7 and 10-6M hGRF the medium GH concentrations tended to increase, but the increase was not statistically significant (Fig. 1) .
Effects of SMS201-995
on the basal and GRF(10-6M)-induced secretion of IR-7B2 and GH by GHl cells As shown in Fig. 2 in the basal secretion of IR-7B2 at the concentration of 10-7M (P <0.01), however, the maximal inhibition was obtained at 10-7M and the higher dose was toxic to the cells. Such inhibition by SMS 201-995 of GH secretion was also noted, but it was not statistically signicant (Fig. 2) . Similarly, hGRF (10-6M)-induced secretion of IR-7B2 was significantly decreased in the presence of SMS201-995 at the concentration of 10-7M (P<0.01) and 10-5M (P<0.05), and this inhibitory effect of SMS 201-995 was maximum at 10-7M (Fig. 3) . GH secretion in the presence of 10-6M hGRF was significantly inhibited by 10-7M SMS 201-995 (P< 0.05) although 10-6M hGRF did not cause a significant increase in the medium GH concentration (Fig. 3) .
Gel permeation chromatography Fig. 4 depicts the elution profiles of the cell extract and culture medium of GH1 cells on a Sephadex G-100 column. One peak of IR-7B2 with an apparent mol wt of 45K was found in the cell extract, whereas a major peak of IR-7B2 with an apparent mol wt of 45K and a minor peak with an apparent mol wt of 13K were found in the culture medium (Fig. 4) .
Discussion
7B2 is a scretory protein of the neuroendocrine tissues of several species (Iguchi et al., 1984; Deng et al., 1986; Natori et al., 1988; Venetikou et al., 1988) . 7B2 is present in human plasma and an increase in plasma 7B2 was noted in some patients with various endocrine tumors (Suzuki et al., 1986; . Increased plasma 7B2 in these patients could be attributed to the secretion of 7B2 by the tumors, although the origin of plasma 7B2 in normal humans is uncertain. Recently, Natori et al.(1988) observed an increase in plasma 7B2 in response to GRF in vivo and a high K+-induced release of 7B2 in vitro in acromegalic patients. However, little is known of the mechanism regulating 7B2 secretion from these tissues. Clonal lines of rat pituitary tumor cells (GH cells) are widely used in studies of the mechanism regulating of pituitary function. Inhibition of membrane adenylate cyclase activity by somatostatin was demonstrated in GH1 cells (Heindel et al., 1978) , but GH release from the cells induced by GRF has not been reported to my knowledge. In GH3 cells, on the other hand, hGRF did not affect either the secretion of GH by the cells or the cellular GH-mRNA concentration (Zeytin et al., 1984) . Thus, we used GH1 cells and studied the responsiveness of these cells to hGRF or somatostatin. IR-7B2 was secreted by GH1 cells and this secretion of IR-7B2 was increased by adding hGRF in a doseresponsive manner. On the other hand, the somatostatin analog SMS201-995 inhibited the basal secretion of IR-7B2 as well as the hGRF-induced IR-7B2 secretion. These protein of the rat GH1 cells and that this secretion of 7B2 is under certain control. In human subjects, on the other hand, an increase in plasma 7B2 after an i. v. bolus infusion of GRF was noted only in patients with acromegaly (Natori et al., 1988) . This suggests the GRF-induced -secretion of 7B2 by the GH secreting pituitary adenoma. 7B2 has been shown to be present in gonadotrophs and thyrotrophs of the rat pituitary gland (Marcikiewicz et al., 1987) . However, present studies together with the suggest the presence of 7B2 in the adenomatous GH secreting cells in the human and rat. 7B2 may be applicable to a clinical utility as a marker for acromegaly.
A significant increase in the medium GH concentration after an addion of 10-5M hGRF was also noted, although its effect on hGRF was weak. This suggests that GH release is induced by hGRF even in GH 1 cells. Such a weak effect of hGRF on the GH secretion by the cells may be due to species' difference of GRF.
The magnitude of the increase or decrease in IR-7B2 and GH in the presence of hGRF or a somatostatin analog were different. This may be attributed to the localization of IR-7B2 and GH in the different secretory granules.
In the analysis of the molecular form of IR-7B2 on gel permeation chromatography, different elution profiles were obtained, i. e. only a 45K-peak in the cell extract and 45K-and 13K-peaks in the culture medium. Earlier studies revealed that the 45k-peak of IR-7B2 obtained by gel permeation chromatography shifted to 20-22K in the analysis on SDS-PAGE under the reduced condition (Iguchi et al., 1984) . The mol wt of 7B2, deduced from the human pituitary cDNA, is 20793 (Martens, 1988) . Thus, the 45K-7B2 could be a dimer. On the other hand, the smaller mol wt form of IR-7B2 (13K) was found only in the culure medium. A 7B2 molecule contains three sites for possible proteolytic cleavage (Martens, 1988) and the N-terminal amino acid sequence of 13K-7B2 was identical with that of 22K-7B2 in the human tissues (Marcinkiewicz et al., 1986) . The 13K-7B2 found in the culture medium in the present study is likely to be a A possible explanation for the presence of 13K-7B2 only in the culture medium is that a 7B2 molecule is processed into small fragments including 13K-7B2 in the secretory granules just before secretion. We cannot exclude the possibility that the 13K-7B2 is a degradation product produced during storage.
